{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T00:13:05Z","timestamp":1781136785943,"version":"3.54.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2018,3,16]],"date-time":"2018-03-16T00:00:00Z","timestamp":1521158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100007924","name":"Bengbu Medical College","doi-asserted-by":"publisher","award":["BYKY1677"],"award-info":[{"award-number":["BYKY1677"]}],"id":[{"id":"10.13039\/501100007924","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Biol Eng Comput"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s11517-018-1811-6","type":"journal-article","created":{"date-parts":[[2018,3,16]],"date-time":"2018-03-16T00:39:33Z","timestamp":1521160773000},"page":"1771-1779","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["An efficient model for auxiliary diagnosis of hepatocellular carcinoma based on gene expression programming"],"prefix":"10.1007","volume":"56","author":[{"given":"Li","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiasheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunming","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanmiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuihua","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,16]]},"reference":[{"key":"1811_CR1","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1002\/hep.27016","volume":"60","author":"K Aleksandrova","year":"2014","unstructured":"Aleksandrova K, Boeing H, Nothlings U, Jenab M, Fedirko V, Kaaks R, Lukanova A, Trichopoulou A, Trichopoulos D, Boffetta P, Trepo E, Westhpal S, Duarte-Salles T, Stepien M, Overvad K, Tjonneland A, Halkjaer J, Boutron-Ruault MC, Dossus L, Racine A, Lagiou P, Bamia C, Benetou V, Agnoli C, Palli D, Panico S, Tumino R, Vineis P, Bueno-de-Mesquita B, Peeters PH, Gram IT, Lund E, Weiderpass E, Quiros JR, Agudo A, Sanchez MJ, Gavrila D, Barricarte A, Dorronsoro M, Ohlsson B, Lindkvist B, Johansson A, Sund M, Khaw KT, Wareham N, Travis RC, Riboli E, Pischon T (2014) Inflammatory and metabolic biomarkers and risk of liver and biliary tract cancer. Hepatology 60:858\u2013871. https:\/\/doi.org\/10.1002\/hep.27016","journal-title":"Hepatology"},{"key":"1811_CR2","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1049\/iet-syb.2015.0082","volume":"10","author":"H Azzawi","year":"2016","unstructured":"Azzawi H, Hou J, Xiang Y, Alanni R (2016) Lung cancer prediction from microarray data by gene expression programming. IET Syst Biol 10:168\u2013178. https:\/\/doi.org\/10.1049\/iet-syb.2015.0082","journal-title":"IET Syst Biol"},{"key":"1811_CR3","doi-asserted-by":"publisher","first-page":"41","DOI":"10.2147\/JHC.S61146","volume":"3","author":"J Balogh","year":"2016","unstructured":"Balogh J, Victor D 3rd, Asham EH, Burroughs SG, Boktour M, Saharia A, Li X, Ghobrial RM, Monsour HP Jr (2016) Hepatocellular carcinoma: a review. J Hepatocell Carcinoma 3:41\u201353. https:\/\/doi.org\/10.2147\/JHC.S61146","journal-title":"J Hepatocell Carcinoma"},{"key":"1811_CR4","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/S0168-8278(01)00130-1","volume":"35","author":"J Bruix","year":"2001","unstructured":"Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, Christensen E, Pagliaro L, Colombo M, Rodes J, HCC EPoEo (2001) Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 35:421\u2013430","journal-title":"J Hepatol"},{"key":"1811_CR5","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1189\/jlb.0506297","volume":"80","author":"A Budhu","year":"2006","unstructured":"Budhu A, Wang XW (2006) The role of cytokines in hepatocellular carcinoma. J Leukoc Biol 80:1197\u20131213. https:\/\/doi.org\/10.1189\/jlb.0506297","journal-title":"J Leukoc Biol"},{"key":"1811_CR6","first-page":"869","volume":"57","author":"BI Carr","year":"2010","unstructured":"Carr BI, Pancoska P, Branch RA (2010) Significance of increased serum GGTP levels in HCC patients. Hepato-Gastroenterology 57:869\u2013874","journal-title":"Hepato-Gastroenterology"},{"key":"1811_CR7","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1148\/radiol.14132361","volume":"272","author":"JY Choi","year":"2014","unstructured":"Choi JY, Lee JM, Sirlin CB (2014) CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part I. Development, growth, and spread: key pathologic and imaging aspects. Radiology 272:635\u2013654. https:\/\/doi.org\/10.1148\/radiol.14132361","journal-title":"Radiology"},{"key":"1811_CR8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/clinchem\/38.1.9","volume":"38","author":"DV Cicchetti","year":"1992","unstructured":"Cicchetti DV (1992) Neural networks and diagnosis in the clinical laboratory: state of the art. Clin Chem 38:9\u201310","journal-title":"Clin Chem"},{"key":"1811_CR9","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.ejps.2011.08.021","volume":"44","author":"EA Colbourn","year":"2011","unstructured":"Colbourn EA, Roskilly SJ, Rowe RC, York P (2011) Modelling formulations using gene expression programming\u2014a comparative analysis with artificial neural networks. Eur J Pharm Sci 44:366\u2013374. https:\/\/doi.org\/10.1016\/j.ejps.2011.08.021","journal-title":"Eur J Pharm Sci"},{"key":"1811_CR10","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1111\/j.1572-0241.2001.04054.x","volume":"96","author":"HB El-Serag","year":"2001","unstructured":"El-Serag HB, Richardson PA, Everhart JE (2001) The role of diabetes in hepatocellular carcinoma: a case-control study among United States veterans. Am J Gastroenterol 96:2462\u20132467. https:\/\/doi.org\/10.1111\/j.1572-0241.2001.04054.x","journal-title":"Am J Gastroenterol"},{"key":"1811_CR11","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.jhep.2011.12.001","volume":"56","author":"European Association For The Study Of The L, European Organisation For R, Treatment Of C","year":"2012","unstructured":"European Association For The Study Of The L, European Organisation For R, Treatment Of C (2012) EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 56:908\u2013943. https:\/\/doi.org\/10.1016\/j.jhep.2011.12.001","journal-title":"J Hepatol"},{"issue":"2","key":"1811_CR12","first-page":"87","volume":"13","author":"C Ferreira","year":"2001","unstructured":"Ferreira C (2001) Gene expression programming: a new adaptive algorithm for solving problems. Complex Systems 13(2):87\u2013129","journal-title":"Complex Systems"},{"key":"1811_CR13","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/S0140-6736(11)61347-0","volume":"379","author":"A Forner","year":"2012","unstructured":"Forner A, Llovet JM, Bruix J (2012) Hepatocellular carcinoma. Lancet 379:1245\u20131255. https:\/\/doi.org\/10.1016\/S0140-6736(11)61347-0","journal-title":"Lancet"},{"key":"1811_CR14","doi-asserted-by":"publisher","first-page":"e47687","DOI":"10.1371\/journal.pone.0047687","volume":"7","author":"HW Hann","year":"2012","unstructured":"Hann HW, Wan S, Myers RE, Hann RS, Xing J, Chen B, Yang H (2012) Comprehensive analysis of common serum liver enzymes as prospective predictors of hepatocellular carcinoma in HBV patients. PLoS One 7:e47687. https:\/\/doi.org\/10.1371\/journal.pone.0047687","journal-title":"PLoS One"},{"key":"1811_CR15","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1055\/s-0038-1634363","volume":"42","author":"PS Heckerling","year":"2003","unstructured":"Heckerling PS, Gerber BS, Tape TG, Wigton RS (2003) Entering the black box of neural networks. Methods Inf Med 42:287\u2013296","journal-title":"Methods Inf Med"},{"key":"1811_CR16","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s12328-015-0568-9","volume":"8","author":"Y Kondo","year":"2015","unstructured":"Kondo Y, Kimura O, Shimosegawa T (2015) Significant biomarkers for the management of hepatocellular carcinoma. Clin J Gastroenterol 8:109\u2013115. https:\/\/doi.org\/10.1007\/s12328-015-0568-9","journal-title":"Clin J Gastroenterol"},{"key":"1811_CR17","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1159\/000343875","volume":"3","author":"M Kudo","year":"2014","unstructured":"Kudo M, Matsui O, Izumi N, Iijima H, Kadoya M, Imai Y, Okusaka T, Miyayama S, Tsuchiya K, Ueshima K, Hiraoka A, Ikeda M, Ogasawara S, Yamashita T, Minami T, Yamakado K, Liver Cancer Study Group of J (2014) JSH consensus-based clinical practice guidelines for the management of hepatocellular carcinoma: 2014 update by the liver cancer study group of Japan. Liver Cancer 3:458\u2013468. https:\/\/doi.org\/10.1159\/000343875","journal-title":"Liver Cancer"},{"key":"1811_CR18","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1007\/s11517-013-1108-8","volume":"51","author":"M Kusy","year":"2013","unstructured":"Kusy M, Obrzut B, Kluska J (2013) Application of gene expression programming and neural networks to predict adverse events of radical hysterectomy in cervical cancer patients. Med Biol Eng Comput 51:1357\u20131365. https:\/\/doi.org\/10.1007\/s11517-013-1108-8","journal-title":"Med Biol Eng Comput"},{"key":"1811_CR19","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/BF00993877","volume":"15","author":"PS Maclin","year":"1991","unstructured":"Maclin PS, Dempsey J, Brooks J, Rand J (1991) Using neural networks to diagnose cancer. J Med Syst 15:11\u201319","journal-title":"J Med Syst"},{"key":"1811_CR20","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.jhep.2004.10.005","volume":"42","author":"JA Marrero","year":"2005","unstructured":"Marrero JA, Fontana RJ, Fu S, Conjeevaram HS, Su GL, Lok AS (2005) Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma. J Hepatol 42:218\u2013224. https:\/\/doi.org\/10.1016\/j.jhep.2004.10.005","journal-title":"J Hepatol"},{"key":"1811_CR21","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1053\/j.gastro.2009.04.005","volume":"137","author":"JA Marrero","year":"2009","unstructured":"Marrero JA, Feng Z, Wang Y, Nguyen MH, Befeler AS, Roberts LR, Reddy KR, Harnois D, Llovet JM, Normolle D, Dalhgren J, Chia D, Lok AS, Wagner PD, Srivastava S, Schwartz M (2009) Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma. Gastroenterology 137:110\u2013118. https:\/\/doi.org\/10.1053\/j.gastro.2009.04.005","journal-title":"Gastroenterology"},{"key":"1811_CR22","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/j.bpg.2008.11.005","volume":"22","author":"R Masuzaki","year":"2008","unstructured":"Masuzaki R, Yoshida H, Tateishi R, Shiina S, Omata M (2008) Hepatocellular carcinoma in viral hepatitis: improving standard therapy. Best Pract Res Clin Gastroenterol 22:1137\u20131151. https:\/\/doi.org\/10.1016\/j.bpg.2008.11.005","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"1811_CR23","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1196\/annals.1310.020","volume":"1020","author":"JF McCarthy","year":"2004","unstructured":"McCarthy JF, Marx KA, Hoffman PE, Gee AG, O'Neil P, Ujwal ML, Hotchkiss J (2004) Applications of machine learning and high-dimensional visualization in cancer detection, diagnosis, and management. Ann N Y Acad Sci 1020:239\u2013262. https:\/\/doi.org\/10.1196\/annals.1310.020","journal-title":"Ann N Y Acad Sci"},{"issue":"Suppl 1","key":"1811_CR24","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1159\/000345891","volume":"84","author":"Y Minami","year":"2013","unstructured":"Minami Y, Kudo M (2013) Therapeutic response assessment of transcatheter arterial chemoembolization for hepatocellular carcinoma: ultrasonography, CT and MR imaging. Oncology 84(Suppl 1):58\u201363. https:\/\/doi.org\/10.1159\/000345891","journal-title":"Oncology"},{"key":"1811_CR25","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1159\/000449337","volume":"5","author":"H Nakanishi","year":"2016","unstructured":"Nakanishi H, Kurosaki M, Tsuchiya K, Yasui Y, Higuchi M, Yoshida T, Komiyama Y, Takaura K, Hayashi T, Kuwabara K, Nakakuki N, Takada H, Ueda M, Tamaki N, Suzuki S, Itakura J, Takahashi Y, Izumi N (2016) Novel pretreatment scoring incorporating C-reactive protein to predict overall survival in advanced hepatocellular carcinoma with sorafenib treatment. Liver Cancer 5:257\u2013268. https:\/\/doi.org\/10.1159\/000449337","journal-title":"Liver Cancer"},{"key":"1811_CR26","doi-asserted-by":"publisher","first-page":"613","DOI":"10.3892\/or.2016.4842","volume":"36","author":"P Reichl","year":"2016","unstructured":"Reichl P, Mikulits W (2016) Accuracy of novel diagnostic biomarkers for hepatocellular carcinoma: an update for clinicians (review). Oncol Rep 36:613\u2013625. https:\/\/doi.org\/10.3892\/or.2016.4842","journal-title":"Oncol Rep"},{"key":"1811_CR27","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.bpg.2014.07.018","volume":"28","author":"N Rich","year":"2014","unstructured":"Rich N, Singal AG (2014) Hepatocellular carcinoma tumour markers: current role and expectations. Best Pract Res Clin Gastroenterol 28:843\u2013853. https:\/\/doi.org\/10.1016\/j.bpg.2014.07.018","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"1811_CR28","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.critrevonc.2011.05.005","volume":"82","author":"A Singhal","year":"2012","unstructured":"Singhal A, Jayaraman M, Dhanasekaran DN, Kohli V (2012) Molecular and serum markers in hepatocellular carcinoma: predictive tools for prognosis and recurrence. Crit Rev Oncol Hematol 82:116\u2013140. https:\/\/doi.org\/10.1016\/j.critrevonc.2011.05.005","journal-title":"Crit Rev Oncol Hematol"},{"key":"1811_CR29","doi-asserted-by":"publisher","first-page":"362","DOI":"10.4254\/wjh.v7.i3.362","volume":"7","author":"J Tejeda-Maldonado","year":"2015","unstructured":"Tejeda-Maldonado J, Garcia-Juarez I, Aguirre-Valadez J, Gonzalez-Aguirre A, Vilatoba-Chapa M, Armengol-Alonso A, Escobar-Penagos F, Torre A, Sanchez-Avila JF, Carrillo-Perez DL (2015) Diagnosis and treatment of hepatocellular carcinoma: an update. World J Hepatol 7:362\u2013376. https:\/\/doi.org\/10.4254\/wjh.v7.i3.362","journal-title":"World J Hepatol"},{"key":"1811_CR30","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/ng0802-339","volume":"31","author":"SS Thorgeirsson","year":"2002","unstructured":"Thorgeirsson SS, Grisham JW (2002) Molecular pathogenesis of human hepatocellular carcinoma. Nat Genet 31:339\u2013346. https:\/\/doi.org\/10.1038\/ng0802-339","journal-title":"Nat Genet"},{"issue":"Suppl 3","key":"1811_CR31","doi-asserted-by":"publisher","first-page":"S242","DOI":"10.1016\/S1590-8658(10)60512-9","volume":"42","author":"S Tremosini","year":"2010","unstructured":"Tremosini S, Reig M, de Lope CR, Forner A, Bruix J (2010) Treatment of early hepatocellular carcinoma: towards personalized therapy. Dig Liver Dis 42(Suppl 3):S242\u2013S248. https:\/\/doi.org\/10.1016\/S1590-8658(10)60512-9","journal-title":"Dig Liver Dis"},{"key":"1811_CR32","doi-asserted-by":"publisher","first-page":"e0158285","DOI":"10.1371\/journal.pone.0158285","volume":"11","author":"HY Wang","year":"2016","unstructured":"Wang HY, Hsieh CH, Wen CN, Wen YH, Chen CH, Lu JJ (2016) Cancers screening in an asymptomatic population by using multiple tumour markers. PLoS One 11:e0158285. https:\/\/doi.org\/10.1371\/journal.pone.0158285","journal-title":"PLoS One"},{"key":"1811_CR33","doi-asserted-by":"publisher","first-page":"e0125517","DOI":"10.1371\/journal.pone.0125517","volume":"10","author":"Z Yu","year":"2015","unstructured":"Yu Z, Lu H, Si H, Liu S, Li X, Gao C, Cui L, Li C, Yang X, Yao X (2015) A highly efficient gene expression programming (GEP) model for auxiliary diagnosis of small cell lung cancer. PLoS One 10:e0125517. https:\/\/doi.org\/10.1371\/journal.pone.0125517","journal-title":"PLoS One"}],"container-title":["Medical & Biological Engineering & Computing"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11517-018-1811-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11517-018-1811-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11517-018-1811-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,29]],"date-time":"2020-10-29T10:15:27Z","timestamp":1603966527000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11517-018-1811-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,16]]},"references-count":33,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["1811"],"URL":"https:\/\/doi.org\/10.1007\/s11517-018-1811-6","relation":{},"ISSN":["0140-0118","1741-0444"],"issn-type":[{"value":"0140-0118","type":"print"},{"value":"1741-0444","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,16]]},"assertion":[{"value":"23 October 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}